Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02296879
What this trial is testing

A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types

Who this might be right for
Solid Tumors
Young Suk Park 16
Testing effectiveness (Phase 2)Study completedNCT03839823
What this trial is testing

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 222
Large-scale testing (Phase 3)Study completedNCT02264990
What this trial is testing

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
AbbVie 595
Large-scale testing (Phase 3)Study completedNCT00686959
What this trial is testing

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 598
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06198907
What this trial is testing

Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)

Who this might be right for
Non-Small-Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Early research (Phase 1)Looking for participantsNCT07387068
What this trial is testing

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Genmab 121
Testing effectiveness (Phase 2)UnknownNCT05681390
What this trial is testing

Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 30
Large-scale testing (Phase 3)Study completedNCT04294810
What this trial is testing

Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 620
Large-scale testing (Phase 3)Looking for participantsNCT06584032
What this trial is testing

Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer

Who this might be right for
Advanced Endometrial Cancer
Hutchmed 412
Early research (Phase 1)Ended earlyNCT04182516
What this trial is testing

Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Nerviano Medical Sciences 52
Testing effectiveness (Phase 2)Looking for participantsNCT06819735
What this trial is testing

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Domain Therapeutics Australia Pty Ltd 125
Testing effectiveness (Phase 2)Study completedNCT05001347
What this trial is testing

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

Who this might be right for
Ovarian CancerHead and Neck CancerNon Small Cell Lung Cancer+3 more
I-Mab Biopharma US Limited 25
Testing effectiveness (Phase 2)Looking for participantsNCT07202364
What this trial is testing

YL202 in Patients With Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerColorectal CancerCervical Cancer+1 more
MediLink Therapeutics (Suzhou) Co., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06137378
What this trial is testing

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

Who this might be right for
Squamous Cell Carcinoma of Head and NeckHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma Stage III+9 more
University of Leipzig 140
Early research (Phase 1)Study completedNCT01363232
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid TumorsSelected Solid Tumors
Array Biopharma, now a wholly owned subsidiary of Pfizer 89
Testing effectiveness (Phase 2)Looking for participantsNCT07032285
What this trial is testing

Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcoma (STS)
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05032040
What this trial is testing

XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Who this might be right for
Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more
Xencor, Inc. 170
Early research (Phase 1)Ended earlyNCT02346955
What this trial is testing

Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)

Who this might be right for
Non-small Cell Lung Carcinoma (NSCLC)MelanomaBladder Cancer+3 more
Famewave Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT04856774
What this trial is testing

Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Next Page